Tennis News

From around the world

Watson into round two at Indian Wells

  • Posted: Mar 10, 2016

British number two Heather Watson reached the second round of the BNP Paribas Open in Indian Wells with a three-set win over Galina Voskoboeva.

Watson, 23, was back in action for the first time since claiming her third WTA title at the Monterrey Open on Sunday.

The world number 53 won the first set on a tie-break before her Kazakh opponent levelled the match, but Watson hit back to win 7-6 (7-4) 4-6 6-1.

“When it was important I was able to bring out my best tennis,” Watson said.

Watson, who was granted a wildcard for the prestigious California tournament after reaching the fourth round last year, plays Romanian 32nd seed Monica Niculescu in round two.

Source link

Meldonium ban 'will cause deaths'

  • Posted: Mar 09, 2016

Sportspeople will die in action as a result of being denied meldonium, according to the heart drug’s inventor.

On Monday, five-time Grand Slam champion Maria Sharapova announced she had tested positive for the drug.

Meldonium, also known as mildronate, was developed to treat diabetes and various heart-related diseases but was banned by the World Anti-Doping Agency (Wada) in January.

“We will see many deaths on the field,” Ivars Calvins told BBC Radio 5 live.

“Athletes who use mildronate will not be able to do it in the future and will be not more protected.”

The Latvian added: “This drug was on the market for 32 years – as a self-protective agent – and now suddenly it becomes forbidden.

“You could see a sudden death in the sports events sometimes.”

Listen to the full interview with the inventor of meldonium

World number seven Sharapova said she has been taking the drug since 2006 for health reasons.

The 28-year-old Russian, who said she was unaware meldonium was added to Wada’s list of banned substances on 1 January, failed a drugs test at the Australia Open later that month.

Sharapova, the highest-paid female athlete in the world in 2015, could be banned for as many as four years.

‘The system works’

Meldonium also has the ability to adjust the body’s use of energy, stimulating glucose metabolism and also helping to clear fatty build-up in the arteries – and could also have a positive effect on stamina and endurance in athletes.

Several athletes has tested positive for it in 2016, including 1500m world champion Abeba Aregawi, 2015 Tokyo Marathon winner Endeshaw Negesse and Russian ice dancer Ekaterina Bobrova.

Thirteen medallists from the 2015 European Games in Baku were also found to have been taking meldonium.

“As far as I’m concerned, the system works,” former Wada president Sir Craig Reedie told BBC Sport.

“There is research on a drug, there is monitoring on a drug, there is information given to the athletes that it will come on to the prohibited list on a set date.

“I can’t believe [there can be any excuse].”

UK Anti-Doping CEO Nicole Sapstead said she could not rule out a British athlete testing positive for meldonium.

“I will never say I’m confident about anything, because the nature of anti-doping is so unpredictable,” she said.

“There’s always a danger that when a new substance is introduced onto the prohibited list that athletes will be caught out. I guess we’ll just have to wait and see.”

Source link

At Home With Jared Donaldson

  • Posted: Mar 09, 2016

At Home With Jared Donaldson

Source link

Are these drugs being misused?

  • Posted: Mar 09, 2016

Perhaps the warning signs were there for tennis player Maria Sharapova before she failed a drugs test for using meldonium.

The substance was added to the World Anti-Doping Agency’s (Wada) list of prohibited substances on 1 January 2016, with five-time Grand Slam champion Sharapova failing a test at the Australian Open later that month.

However, meldonium, which is thought to improve an athlete’s stamina and endurance, featured on Wada’s watch list in 2015 – meaning it was not banned but was being monitored “in order to detect patterns of misuse in sport”.

For a substance to be added to Wada’s prohibited list involves a three-stage consultation process, which lasts several months and includes input from Wada experts, its health, medical and research committee (HMRC) and its executive committee.

According to Wada, a substance may be “considered” for the prohibited list if it meets two of the following three criteria:

  • Enhances performance
  • Poses a threat to athlete health
  • Violates the spirit of sport

A substance can be added to the prohibited list without first featuring on the watch list.

Meldonium – or mildronate as it was known to 28-year-old Russian Sharapova – is no longer on the 2016 watch list, but several other substances remain on it.

Some are monitored only during competition, some outside of competition and some both in and out of competition.

Which substances are on Wada’s 2016 watch list?

Stimulants

  • Bupropion – anti-depressant
  • Caffeine – banned for 20 years until 2004
  • Nicotine
  • Phenylephrine and phenylpropanolamine – decongestants
  • Pipradrol – counters fatigue
  • Synephrine – found in weight-loss and energy products

Narcotics

  • Mitragynine – natural occurring plant compound said to aid recovery
  • Tramadol – strong painkiller

Glucocorticoids – anti-inflammatories

Telmisartan – used for high blood pressure

Read more on Sharapova’s failed drugs test
Cool, calculated and candid Sharapova?
Sharapova was ‘reckless beyond description’ – ex-Wada boss
How can Meldonium help an athlete?
Williams says Sharapova showed ‘courage’

Source link

Safin Elected To International Tennis Hall Of Fame

  • Posted: Mar 09, 2016

Safin Elected To International Tennis Hall Of Fame

Charismatic and powerful right-hander becomes first Russian inductee

Former World No. 1 Marat Safin has been elected to the International Tennis Hall of Fame. The Class of 2016 induction ceremony will take place on 16 July, during the Hall of Fame Tennis Championships.

Safin, the first Russian player to be inducted into the International Tennis Hall of Fame, said, “I’m very happy to be inducted to the Hall of Fame. I want to say thank you to everyone who helped me and supported me throughout my tennis career. To be part of a Hall of Fame is every athlete’s dream. I am really honored to be inducted and proud to represent Russian tennis alongside the greatest champions of tennis history.”

Safin won 15-tour-level titles, including the 2000 US Open (d. Sampras), the 2005 Australian Open (d. Hewitt) and five ATP World Tour Masters 1000 trophies. He helped Russia clinch the Davis Cup in 2002 and 2006. Since retiring in late 2009, Safin has served on the Russian Olympic Committee and has worked with the Russian Tennis Federation. In 2011, he was elected to serve in the Russian Federal Parliament.

Former WTA No. 1 Justine Henin, a winner of seven major titles, Yvon Petra and Margaret ‘Peggy’ Scriven will also be inducted.

“It is a pleasure to announce the induction of Justine Henin and Marat Safin into the International Tennis Hall of Fame,” said Stan Smith, who serves as the International Tennis Hall of Fame President and Chairman of the Enshrinee Nominating Committee. “Justine and Marat committed themselves to the sport and worked relentlessly at being champions of the highest calibre.

“As a result, they achieved extraordinary careers with world No. 1 rankings and Grand Slam tournament victories. They led their nations to victories in Fed Cup and Davis Cup. They are rightfully a source of national pride in Belgium and Russia, and we are looking forward to welcoming them as the very first Hall of Fame inductees from those nations.”

Source link

New deal for GB Davis Cup captain Smith

  • Posted: Mar 09, 2016

Leon Smith has signed a new contract to remain Great Britain Davis Cup captain for the next three years.

The Scot succeeded John Lloyd in 2010, when GB were on the verge of relegation to the competition’s bottom tier.

In November, Smith led the team to their first Davis Cup title in 79 years with a 3-1 victory over Belgium.

“It is a huge honour and privilege to continue captaining our Davis Cup Team,” said Smith, whose side have won 13 of their last 15 ties.

“We have achieved so much over the last six years and becoming world champions last year will be the highlight of my career.

“I’m really excited at the opportunity to continue working with this group of players, support staff and of course our fans. Our Davis Cup journey has captured the imagination of so many people across the country and I’m looking forward to using our Davis Cup successes as a way to get more kids playing tennis.”

Lawn Tennis Association chief executive Michael Downey said he was delighted about Smith’s contract extension.

“As I said after Leon led the Great Britain team to the title in Ghent, we are lucky to have the world’s best Davis Cup captain lead our nation,” he added.

Andy Murray helped Britain to a 3-1 victory over Japan in the Davis Cup 2016 first round last weekend. They will play Serbia away in July’s quarter-finals.

Source link

Djokovic Heads Indian Wells Draw

  • Posted: Mar 09, 2016

Djokovic Heads Indian Wells Draw

Two-time defending champion on quarter-final collision course with Tsonga

As the ATP World Tour shifts to the Californian desert this week, Novak Djokovic’s focus will be fixed firmly on another record. The top seed and two-time defending champion arrives at Indian Wells with a 16-1 record for the season and begins his quest for an unprecedented fifth BNP Paribas Open title.

The Serb receives a first-round bye before opening his bid against either a qualifier or Russian Teymuraz Gabashvili. Djokovic is on track to face Spanish 14th seed Roberto Bautista Agut in the fourth round and should the draw continue according to seedings, he would carry a 14-6 FedEx ATP Head2Head record into a quarter-final clash with French seventh seed Jo-Wilfried Tsonga. Djokovic has not fallen to the Frenchman since 2014 and Tsonga would likely have to make his way first past the winner of a third-round showdown between Austrian 11th seed Dominic Thiem or American 22nd seed Jack Sock.

See The Draw

Should he reach the semi-finals, Djokovic would likely square off against either fourth seed and three-time former champion Rafael Nadal or fifth seed Kei Nishikori. After his first-round bye, Nadal is slated to meet either Luxembourg’s Gilles Muller or Victor Estrella Burgos of the Dominican Republic in the second round and could run into his Australian Open conqueror, countryman Fernando Verdasco, in the third round. French 16th seed Gilles Simon is his projected fourth-round opponent before an expected clash with Japan’s Nishikori, a player he owns a 7-1 FedEx ATP Head2Head record against. Nishikori meets either Kazakhstan’s Mikhail Kukushkin or Spaniard Daniel Munoz de la Nava in the second round and a dangerous fourth-round showdown with big-serving American John Isner lurks. The pair has split two previous meetings.

Andy Murray heads the bottom half of the draw as the No.2 seed. The Scot will be attempting to claim a first BNP Paribas Open title, with his best result being a runner-up showing in 2009. Murray opens against either Bosnian Damir Dzumhur or Spaniard Marcel Granollers and could face the winner of a blockbuster third-round showdown between two of the tour’s flashiest shot-makers, Gael Monfils and Nick Kyrgios, in the fourth round. Monfils leads Kyrgios 1-0 in their FedEx ATP Head2Head series, while Murray would carry a combined 8-2 lead into a clash with either the Frenchman or the Australian.

A quarter-final date with Czech sixth seed Tomas Berdych is on the cards. Murray would take a narrow 7-6 FedEx ATP Head2 Head lead into that match. Berydch faces one of the more difficult routes of the Top 8 seeds to the quarter-finals. The 30-year-old will take on either a qualifier or 2013 runner-up, Juan Martin del Potro in the second round. Del Potro, playing just his second tournament on his road back from surgery, remains the last player to defeat Djokovic at Indian Wells and holds a 4-2 record against Berdych, although the two haven’t met since 2012.

A fourth-round meeting with either Australian Bernard Tomic or Canadian 12th seed Milos Raonic is projected for Berdych. Raonic reached the semi-finals in the desert last year on the back of his first victory over Nadal.

Swiss third seed Stan Wawrinka would be the likely semi-final opponent of a Murray-Berdych winner. Wawrinka is yet to make it past the quarter-finals at the BNP Paribas Open and would potentially have to down eighth seed Richard Gasquet to do so. Wawrinka trails the Frenchman 1-2 and Murray 7-8 in their FedEx ATP Head2Head records. He faces either Russian Dmitry Tursunov or Ukraine’s Illya Marchenko in the second round with Belgian 15th seed David Goffin on track for a fourth-round clash.

Eight Next Generation players – potentially nine if Andrey Rublev continues through qualifying – will contest the BNP Paribas main draw, including six teenagers. Two of them, Taylor Fritz and Frances Tiafoe will square off for the first time in an all-American battle in the opening round. German 18 year old Alexander Zverev opens against Croatian Ivan Dodig before a potential second-round meeting with Grigor Dimitrov, while Dodig’s countryman, 19-year-old Borna Coric starts against Frenchman Lucas Pouille before a potential match with Thomaz Bellucci.

Source link

Sharapova 'reckless beyond description'

  • Posted: Mar 08, 2016

Maria Sharapova’s failed drugs test was “reckless beyond description”, according to former World Anti-Doping Agency president Dick Pound.

Sharapova, 28, revealed on Monday that she tested positive for the banned substance meldonium in January.

A number of sponsors have already distanced themselves from the Russian five-time Grand Slam winner.

“Running a $30m business depends on you staying eligible to play tennis,” Pound told BBC Sport.

‘There must have been a doctor following this’

Meldonium, which Sharapova said she has taken since 2006 for health reasons, became a banned substance on 1 January.

It is on the banned list now because Wada started seeing it in lots of samples and found it does have performance-enhancing properties.

“You are taking something on a list. I am sorry, that is a big mistake – of course she should have known,” said Pound, who was head of Wada from 1999 to 2007.

“She is taking something that is not generally permitted in her country of residence [USA] for medical purposes, so she says, so there must be a doctor following this.

“Anytime there is a change to the list, notice is given on 30 September prior to the change. You have October, November, December to get off what you are doing.

“All the tennis players were given notification of it and she has a medical team somewhere. That is reckless beyond description.”

‘There is a side effect to every drug’

The ability to increase oxygen movement to muscles has seen meldonium used as a supplement for athletes, as it could have a positive affect on stamina and endurance.

Pound said: “A drug like this over a long period of time is contraindicated. It means you would not take it over a long period of time. That is why there was an urge to put the drug on the list. A lot of people were taking it for performance enhancing.

“Most of the drugs of choice for dopers were built for therapeutic reasons – like EPO and others. That was supposed to regenerate blood if you had cancer treatment or surgical intervention if you needed to increase blood supply.

“Someone has said: ‘Hmm, more oxygen in the blood? Hmm, very interesting. Let’s see if we can use it for that purpose.’

“There is a side effect to every drug, somebody must be monitoring this.”

‘Wada can ask for an increased ban’

The International Tennis Federation said Sharapova will be provisionally suspended from 12 March. She faces up to a four-year ban.

“We have now increased the basic penalty for a first offence from two to four years,” added 73-year-old Pound.

“If there is absolutely zero fault on the part of the athlete, where you can get a reduction of half of that suspension period, you are looking at a couple of years.

“That is for the tennis association to propose. If Wada does not agree, it will appeal to the Court of Arbitration for Sport for an increase.”

‘Sharapova – a media darling’

Sharapova made her announcement at a hotel in Los Angeles on Monday and her admission has polarised opinions.

World number one Serena Williams, who had beaten Sharapova in the quarter-finals of the Australian Open on 26 January before she tested positive, has said the Russian has shown “a lot of courage” for accepting responsibility.

However, Jeanette Kwakye, 100m finalist for Great Britain at the 2008 Beijing Olympics, has criticised Sharapova and feels she may be given a light sentence.

“What we have in Maria Sharapova is a media darling. She knows how to work the world of media, she knows how to spin and put things in her favour by breaking her own news,” said Kwakye.

“For somebody like her, it may be a lenient slap on the wrist. There seems to be a different rule for her.”

More on Sharapova
Sharapova showed ‘courage’ over failed drugs test
Cool, calculated and candid Sharapova?
Meldonium – how can it help an athlete?
Sharapova showed ‘courage’ over failed test – Williams
Sharapova reveals failed drugs test

Source link

Introducing The Next Generation

  • Posted: Mar 08, 2016

Introducing The Next Generation

Source link

Meldonium – how can it help an athlete?

  • Posted: Mar 08, 2016

Meldonium was barely on the radar until five-time Grand Slam champion Maria Sharapova revealed she recorded a positive drugs test for the substance.

The Russian, 28, has been taking the drug since 2006 for health issues.

But it was banned by the World Anti-Doping Agency (Wada) on 1 January and the former world number one has now been provisionally suspended from 12 March, meaning she could face a suspension of up to four years.

A lot of athletes take it – possibly for medical reasons – but where has it come from? Will we be hearing more about it? And can you buy it?

Watch how Sharapova revealed she failed test

What is meldonium?

Meldonium – also known as mildronate – is a drug designed to treat ischemia, a condition where there is a reduction in blood supply to body tissue. It is also said to have benefits for diabetes sufferers.

Dr Tom Bassindale, lecturer in forensic science at Sheffield Hallam University, said: “It has been developed and used in Latvia and was approved in the early 2000s to treat diabetes and various heart-related diseases through its ability to adjust the body’s use of energy, stimulating glucose metabolism and also helping to clear fatty build-up in the arteries.”

Why would an athlete benefit from it?

The ability to increase oxygen movement to muscles has seen meldonium used as a supplement for athletes, as it could have a positive effect on stamina and endurance.

Dr Bassindale said: “It’s advertised as giving a mental focus, removing external stress so you feel sharper. There is a slight central nervous system effect, like with stimulants such as caffeine, which gives you a sharper edge.

“But it will aid recovery quicker from a hard effort – whether that’s playing multiple games of tennis or a cyclist coming back the next day for another stage. There is also an endurance effect.”

Can I buy it legally?

In a word: yes. It is not licensed in the UK, so is therefore illegal to sell. But it is not illegal to import it from abroad for personal use.

Russian supplements website RUPharm told BBC Sport it is has sold 150 packets of the drug in the most recent 24 hours, compared with 850 total sales in the past 12 months.

“As a joke we now call mildronate the Sharaponate,” said a spokesperson for the website.

Most of their sales are to UK and USA customers and the majority are for sport, rather than medicinal, use.

But the UK government’s Medicines & Healthcare Products Regulatory Agency says it urges people to not buy unlicensed drugs from abroad, as there is no guarantee that customers know if the product is safe.

Is it safe?

Assuming the product is what it says on the label, there are no tests that show any serious side effects.

A Latvian manufacturer of the product – OlainFarm – says it is possible that some using the drug will suffer “headaches” and “agitation”. It is also possible for there to be some skin irritation, though this is “very rare”.

RUPharma said: “We do not know of any negative side effects, unless of course one overdoses. But that applies to any product or medicine.”

Dr Bassindale added that he would expect it to have “gone through significant testing” in Latvia.

Is it used a lot?

Last year, as part of Wada’s monitoring of meldonium, a Cologne testing centre found that 182 of 8,320 random urine samples gave positive results for the drug – a rate of 2.2%.

“That’s huge,” says Dr Bassindale. “The overall positive tests for all other doping was about 2% from 280,000 tests.”

BBC Russian’s Pavel Fendenko said the drug is frequently sold over the counter in Russia and prescribed by cardiologists.

“In 2013, the Russian government put it on a list of essential drugs – on a par with things like insulin – which makes it subject to certain price caps,” he said.

Why is it now banned?

After Wada monitored use of meldonium, it decided the drug would be included on the banned list from 1 January.

Dr Bassindale said: “When deciding whether to ban a drug, Wada looks at three things. Will it enhance performance? Is it detrimental to the health of an athlete? Is it against the ‘spirit of sport’?

“To be banned, a drug must ‘fail’ two of these three tests. Presumably, in this case, they have decided the drug is against the ‘spirit of sport’.”

Will we see more failed tests?

If 2.2% of random samples showed levels of the drug, then it is being widely used. However, it is impossible to tell how many of those samples take it for legitimate medical reasons and would therefore be able to get a therapeutic usage exemption.

But Dr Bassindale says the high-profile nature of Sharapova’s positive test may reduce the number of athletes using meldonium.

“This might have persuaded people to be much more careful,” he said.

Source link